VEEVA SYSTEMS INC

Veeva Systems’ senior officer sells 1,000 shares—what does this mean for the healthcare tech leader’s stock and future prospects? Discover the insights.

Veeva launches Falcon Safety, a unified E2B‑compatible platform, and crowns ACTO a Gold Product Partner—boosting cloud‑based safety, compliance, and life‑sciences collaboration.

Veeva’s Q2 2026 earnings hit a record 40% jump in operating income, sparking analyst target hikes to $275‑$325 and a new 52‑week high in shares.

Veeva Systems’ rise in active funds signals a shift away from pure index play, offering investors high‑growth cloud software with strong fundamentals.

Veeva Systems surges as its new EHS app expands Quality Cloud, boosting investor confidence with a strong GF score and promising growth in the expanding life‑sciences SaaS market.

Veeva Systems’ June 2026 shareholder meeting confirmed strong leadership support and KPMG’s audit approval, reinforcing governance and stability for its $24.9 bn market‑cap cloud software firm.

Veeva Quality Cloud adoption by Kindeva boosts manufacturing efficiency, scalability and compliance for life‑sciences, driving Veeva’s growth and market confidence.

Veeva Systems joins the S&P 500, sparking a 10 % stock jump as investors praise its cloud‑based life‑sciences software and forecast continued growth.

Veeva Systems’ latest quarterly report shows a $182.57 share price and $30B market cap, yet high P/E and price‑to‑book ratios raise questions about its valuation and future growth.

Veeva Systems boosts its life‑sciences edge as 13 of the largest biopharma firms adopt its Link Key People platform, adding AI tools and APIs that standardize engagement data for faster decision‑making and future growth.